Indications
Croup. Bronchospasm such as asthma or COPD. Adrenal insufficiency, long-term steroid dependence, or fluid-refractory shock. Acute mountain sickness and high altitude cerebral edema (HACE).
Contraindications
Known hypersensitivity, systemic fungal infection, cerebral malaria
Adult dose
Bronchospasm (asthma, COPD): 0.6 mg/kg PO (the IV solution can be given PO), or IV or IM if critically ill, max 16 mg
Adrenal insufficiency, long-term steroid dependence, or fluid-refractory shock needing vasopressors: 0.6 mg/kg IV or IM, max 16 mg. Hydrocortisone is preferred if available
Acute mountain sickness: 4 mg IM, IV or PO every 6 hours until symptoms resolve
HACE: 8 mg IM, IV or PO once, then 4 mg every 6 hours
Pediatric dose
Croup: 0.6 mg/kg PO, IV or IM, max 16 mg
Bronchospasm (asthma), age 2 and older: 0.6 mg/kg PO, or IV or IM if critically ill, max 16 mg
Adrenal insufficiency, long-term steroid dependence, or fluid-refractory shock needing vasopressors: 0.6 mg/kg IV or IM, max 16 mg. Hydrocortisone is preferred if available
Acute mountain sickness: 0.15 mg/kg IM, IV or PO every 6 hours, max single dose 4 mg
HACE: 0.15 mg/kg per dose every 6 hours
Route
PO, IV, IM
Special considerations
One dose of dexamethasone works as well as several days of other steroids, which is why it's the preferred PO steroid. For altitude illness, descent comes first: dexamethasone treats the symptoms and does not speed acclimatization. For adrenal insufficiency, hydrocortisone is preferred. Steroids have no proven benefit in allergic reactions or anaphylaxis, and should not be given for bronchiolitis.
Follow your local protocols. Sources: National Model EMS Clinical Guidelines (NASEMSO, 2022): Pediatric Respiratory Distress (Croup); Respiratory Distress (Includes Bronchospasm, Pulmonary Edema); Shock; Altitude Illness; Anaphylaxis and Allergic Reaction; Pediatric Respiratory Distress (Bronchiolitis). Levels from the National EMS Scope of Practice Model (2019).